Invention Grant
- Patent Title: Diacylglycerol acyltransferase 2 inhibitors
-
Application No.: US15693785Application Date: 2017-09-01
-
Publication No.: US10188653B2Publication Date: 2019-01-29
- Inventor: Kentaro Futatsugi
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent A. Dean Olson
- Main IPC: A61K31/506
- IPC: A61K31/506 ; A61K31/5377 ; A61K31/606 ; A61K31/4545 ; A61K45/06 ; C07D491/08 ; C07D487/02 ; C07D413/14 ; C07D401/14 ; C07D487/04 ; C07D401/04
Abstract:
Compounds of Formula I that inhibit the activity of the diacylglycerol acyltransferase 2 (DGAT2) and their uses in the treatment of diseases linked thereto in animals are described herein.
Public/Granted literature
- US20180042926A1 DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS Public/Granted day:2018-02-15
Information query
IPC分类:
